Primary localized amyloidosis of the eyelid: Two cases of immunoglobulin light chain-derived proteins, subtype λ V respectively λVI

Clinical and Experimental Immunology

Volumn 106, Issue 2, 1996, Pages 362-366

  Olsen, K E ^a   Sandgren, O ^b   Sletten, K ^c   Westermark, P ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

amyloid; conjunctiva; immunoglobulin; lambda

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; CASE REPORT; EYELID; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0029844722     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-830.x     Document Type: Article

References (27)

1. Husby G, Sletten K, Blumenkrantz N, Danielsen L. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as λ immunoglobulin light chains of variable subgroup I(AλI). Clin Exp Immunol 1981; 45:90-6.
2. Westermark P, Sletten K, Pitkänen P, Natvig JB, Lindholm CE. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL. Mol Immunol 1982; 19:447-50.
3. Sletten K, Westermark P, Pitkänen P, Thyresson N, Olstad OK. Amino acid sequences in amyloid proteins of κIII immunoglobulin light-chain origin. Scand J Immunol 1983; 18:557-60.
4. Kitjima Y, Hirata H, Kagawa Y, Yaoita H. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to λ immunoglobulin light chain of variable subgroup III (AλIII). J Invest Dermatol 1990; 95:301-3.
5. Linke RP, Gerhard L, Lottspeich F. Brain-restricted amyloidoma of immunoglobulin λ-light chain origin clinically resembling multiple sclerosis. Biol Chem Hoppe-Seyler 1992; 373:1201-9.
6. Vidai RG, Ghiso J, Gallo G, Cohen M, Gambetti P-L, Frangione B. Amyloidoma of the CNS. II. Immunohistochemical and biochemical study. Neurology 1992; 42:2024-8.
7. Berg AM, Troxler RF, Grillone G, Kasznica J, Kane K, Cohen AS, Skinner M. Localized amyloidosis of the larynx: evidence for light chain composition. Ann Otol Rhinol Laryngol 1993; 102:884-9.
8. Eriksson L, Sletten K, Benson L, Westermark P. Tumour-like localized amyloid of the brain is derived from immunoglobulin light chain. Scand J Immunol 1993; 37:623-6.
9. Miura K, Shirsawa H. Lambda III subgroup immunoglobulin light chains are precusor proteins of nodular pulmonary amyloidosis. Am J Clin Pathol 1993; 100:561-6.
10. Vigushin DM, Hawkins PN, Hsuan JJ, Totty NF, Pepys MB. ALκ, amyloid in a solitary extradural lymphoma. J Neurol Neurosurg Psychiatry 1994; 57:751-4.
11. Eilam O, Liepnieks JJ, WeisbergerE, Benson MD. Plasmacytoma of the nasal cavity with lambda III amyloid deposition. Amyloid: Int J Exp Invest 1995; 2:31-35.
12. Tan SY, Murdoch IE, Sullivan TJ, Wright JE, Truong O. Primary localized orbital amyloidosis composed of the immunoglobulin γ heavy chain CH3 domain. Clin Sci 1994; 87:487-91.
13. Lucas DR, Knox F, Davies S. Apparent monoclonal origin of lymphocytes and plasma cells infiltrating ocular adnexal amyloid deposits: report of 2 cases. Br J Ophthalmol 1982; 66:600-6.
14. Schaldenbrand JD, Keren DF. IgD amyloid in IgD-λ monoclonal conjunctival amyloidosis. Arch Pathol Lab Med 1983; 107:626-8.
15. Borodic GE, Beyer-Machule CK, Millin J, Conte J, Foster CS. Immunoglobulin depositions in localized conjunctival amyloidosis. Am J Ophthalmol 1984; 98:617-22.
16. Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47:924-33.
17. Blobel G, Dobberstein B. Transfer of proteins aeross membranes. J Cell Biol 1475; 67:835-51.
18. Fontana A. Modification of tryptophan with BNPS-skatole (2-(2-nitrophenylsulfenyl)-3-methyl-3-bromoindolenine). Meth Enzymol 1472; 25:419-23.
19. Kabat EH, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest. Vol 1, 5th Ed. US Department of Health and Human Services, PHS, NIH. 1991.
20. Solomon A, Frangione B, Franklin EC. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the Vw1 subgroup of human light chains with amyloidosis AL(λ). J Clin Invest 1982; 70:453-60.
21. Hurle MR, Helms LR, Li L, Chan W, Wetzel R. A role for destabilizing amino acid replacements in light-chain amyloidosis. Proc Natl Acad Sci USA 1994; 91:5446-50.
22. Stevens FJ, Myatt EA, Chang C-H, Westholm EA, Eulitz M, Weiss DT, Murphy C, Solomon A, Schiffer M. A molecular model for sell-assembly of amyloid fibrils: Immunoglobulin light chains. Biochemistry 1995; 34:10697-702.
23. Eulitz M, Linke R. Amyloid fibrils derived from V-region together with C-region fragments from λII-immunoglobulin light chain (HAR). Biol Chem Hoppe-Seyler 1985; 366:907-15.
24. Sletten K, Natvig JB, Husby G, Juul J. The complete amino acid sequence of a prototype immunoglobuli-λ light-chain-type amyloid-fibril protein AR. Biochem J 1981; 195:561-72.
25. Fett JW, Deutsch HF. Primary structure of the Meg λ chain. Biochemistry 1974; 13:4102-14.
26. Wikler M, Putman FW. Amino acid sequence of human λ chains. J Biol Chem 1970; 245:4488-507.
27. Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Quart J Med 1993; 86:365-74.